Graph theoretical analysis of the structural connectivity in progressive supranuclear palsyin relation to tau burden: A [18F]PI-2620 PET/MRI study

被引:0
|
作者
Aghakhanyan, G. [1 ,2 ,3 ]
Rullmann, M. [3 ]
Rumpf, J. [4 ]
Schroeter, M. L. [5 ]
Patt, M. [3 ]
Classen, J. [4 ]
Sabri, O. [3 ]
Barthel, H. [3 ]
机构
[1] Univ Hosp Pisa, Reg Ctr Nucl Med, Pisa, Italy
[2] Univ Pisa, Dept Translat Res New Technol Med & Surg, Pisa, Italy
[3] Univ Leipzig, Dept Nucl Med, Leipzig, Germany
[4] Univ Leipzig, Dept Neurol, Leipzig, Germany
[5] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-193
引用
收藏
页码:S95 / S95
页数:1
相关论文
共 47 条
  • [41] Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies
    Heiko Kroth
    Felix Oden
    Jerome Molette
    Hanno Schieferstein
    Francesca Capotosti
    Andre Mueller
    Mathias Berndt
    Heribert Schmitt-Willich
    Vincent Darmency
    Emanuele Gabellieri
    Cédric Boudou
    Tanja Juergens
    Yvan Varisco
    Efthymia Vokali
    David T. Hickman
    Gilles Tamagnan
    Andrea Pfeifer
    Ludger Dinkelborg
    Andreas Muhs
    Andrew Stephens
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 2178 - 2189
  • [42] Multi-Center Study on 3R Pick Tau Imaging with [18F]PI-2620 in Frontotemporal Lobar Degeneration
    Barthel, Henryk
    Brendel, Matthias
    Villemagne, Victor
    Marek, Ken
    Van Eimeren, Thilo
    Rullmann, Michael
    Willmer, Franziska
    Messerschmidt, Konstantin
    Schroeter, Matthias
    Saur, Dorothee
    Levin, Johannes
    Perneczky, Robert
    Patt, Marianne
    Classen, Joseph
    Seibyl, John
    Drzezga, Alexander
    Bartenstein, Peter
    Sabri, Osama
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [43] Association of Neurofilament Light Chain, [18F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid-Negative CBS
    Palleis, Carla
    Franzmeier, Nicolai
    Weidinger, Endy
    Bernhardt, Alexander M.
    Katzdobler, Sabrina
    Wall, Stephan
    Ferschmann, Christian
    Harris, Stefanie
    Schmitt, Julia
    Schuster, Sebastian
    Gnoerich, Johannes
    Finze, Anika
    Biechele, Gloria
    Lindner, Simon
    Albert, Nathalie L.
    Bartenstein, Peter
    Sabri, Osama
    Barthel, Henryk
    Rupprecht, Rainer
    Nuscher, Brigitte
    Stephens, Andrew W.
    Rauchmann, Boris-Stephan
    Perneczky, Robert
    Haass, Christian
    Brendel, Matthias
    Levin, Johannes
    Hoeglinger, Guenter U.
    NEUROLOGY, 2024, 102 (01)
  • [44] Generative Adversarial Network-Enhanced Ultra-Low-Dose [18F]-PI-2620 t PET/MRI in Aging and Neurodegenerative Populations
    Chen, K. T.
    Tesfay, R.
    Koran, M. E. I.
    Ouyang, J.
    Shams, S.
    Young, C. B.
    Davidzon, G.
    Liang, T.
    Khalighi, M.
    Mormino, E.
    Zaharchuk, G.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2023, 44 (09) : 1012 - 1019
  • [45] High-yielding automated radiosynthesis of [18F]-Tau PET tracers, TAUVID and PI-2620 using 2-nitropyridyl-N-tritylated precursors
    Neelamegam, Ramesh
    Neelamegam, Ramesh
    Kumar, Dileep
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [46] Clinical evaluation of 18F-PI-2620, a next generation tau PET agent in subjects with Alzheimer's disease, progressive supranuclear palsy, and non-demented controls
    Seibyl, J.
    Barret, O.
    Stephens, A.
    Madonia, J.
    Alagille, D.
    Mueller, A.
    Schieferstein, H.
    Berndt, M.
    Kroth, H.
    Bullich, S.
    Papin, C.
    Carroll, V.
    Sandiego, C.
    Pfeifer, A.
    Muhs, A.
    Dinkelborg, L.
    Tamagnan, G.
    Marek, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S252 - S252
  • [47] Cerebral Tau Deposition in Comorbid Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis: An [18F]-Flortaucipir and 7T MRI Study
    Cheong, Ian
    Du, Yong
    Smith, Gwenn
    Hua, Jun
    Li, Xu
    Pantelyat, Alexander
    NEURODEGENERATIVE DISEASES, 2024, 23 (3-4) : 35 - 42